NO20070123L - Ny svaert selektiv amideringsmetode - Google Patents

Ny svaert selektiv amideringsmetode

Info

Publication number
NO20070123L
NO20070123L NO20070123A NO20070123A NO20070123L NO 20070123 L NO20070123 L NO 20070123L NO 20070123 A NO20070123 A NO 20070123A NO 20070123 A NO20070123 A NO 20070123A NO 20070123 L NO20070123 L NO 20070123L
Authority
NO
Norway
Prior art keywords
carboxylic acid
carboxyl group
highly selective
new highly
amidation method
Prior art date
Application number
NO20070123A
Other languages
English (en)
Inventor
Atsushi Inagaki
Misayo Sera
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20070123L publication Critical patent/NO20070123L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Den foreliggende oppfinnelsen tilveiebringer en industriell produksjonsmetode med et hurtig prosessforløp med et høyt utbytte av alifatisk cyklisk karboksamid med karboksylgruppe, omfattende funksjonell gruppeselektiv reaksjon ved bruk av et billig kondenseringsmiddel uten å beskytte karboksylgruppen ved forestring, dvs. at det oppnådde karboksylsyreanhydridet omsettes ved å reagere karboksylsyre og tertiært karboksylsyrehalogenid med alifatisk cyklisk sekundært amin med karboksylgruppe.
NO20070123A 2004-06-11 2007-01-08 Ny svaert selektiv amideringsmetode NO20070123L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004174417 2004-06-11
PCT/JP2005/011091 WO2005121133A1 (en) 2004-06-11 2005-06-10 Highly selective novel amidation method

Publications (1)

Publication Number Publication Date
NO20070123L true NO20070123L (no) 2007-03-07

Family

ID=34970324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070123A NO20070123L (no) 2004-06-11 2007-01-08 Ny svaert selektiv amideringsmetode

Country Status (16)

Country Link
US (1) US20070238721A1 (no)
EP (1) EP1753752A1 (no)
JP (1) JP2008501629A (no)
CN (1) CN101001854A (no)
AU (1) AU2005252111A1 (no)
BR (1) BRPI0511877A (no)
CA (1) CA2569686A1 (no)
CR (1) CR8803A (no)
IL (1) IL179308A0 (no)
MA (1) MA28688B1 (no)
MX (1) MXPA06014152A (no)
NO (1) NO20070123L (no)
RU (1) RU2006147285A (no)
TW (1) TW200604187A (no)
WO (1) WO2005121133A1 (no)
ZA (1) ZA200609972B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009108700A1 (en) 2008-02-25 2009-09-03 Sixpoint Materials, Inc. Method for producing group iii nitride wafers and group iii nitride wafers
DE102008054612A1 (de) * 2008-12-15 2010-06-17 Evonik Röhm Gmbh Verfahren zur Herstellung von N-Isopropyl(meth)acrylamid
TWI774767B (zh) * 2017-05-12 2022-08-21 瑞士商多蒂孔股份有限公司 茚烷衍生物及其在有機電子產品的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2140003A (en) * 1983-04-13 1984-11-21 Shell Int Research Azetidine derivatives suitable for inducing male sterility in plants
JP3479796B2 (ja) * 1995-09-13 2003-12-15 武田薬品工業株式会社 ベンゾオキサゼピン化合物
PT862562E (pt) * 1995-09-13 2001-11-30 Takeda Chemical Industries Ltd Compostos de benzoxazepina sua producao e utilizacao como agentes para reducao dos niveis de lipidos
WO2002038180A1 (en) * 2000-11-09 2002-05-16 Takeda Chemical Industries, Ltd. High-density lipoprotein-cholesterol level elevating agent
JP4138299B2 (ja) * 2000-11-09 2008-08-27 武田薬品工業株式会社 高密度リポタンパク−コレステロール上昇剤
DE60106497D1 (de) * 2001-04-30 2004-11-18 Lupin Lab Ltd Ein verfahren zur herstellung von natrium fosinopril

Also Published As

Publication number Publication date
MA28688B1 (fr) 2007-06-01
MXPA06014152A (es) 2007-01-29
CR8803A (es) 2007-04-20
BRPI0511877A (pt) 2008-01-15
JP2008501629A (ja) 2008-01-24
ZA200609972B (en) 2008-08-27
WO2005121133A1 (en) 2005-12-22
US20070238721A1 (en) 2007-10-11
CN101001854A (zh) 2007-07-18
IL179308A0 (en) 2007-03-08
TW200604187A (en) 2006-02-01
AU2005252111A1 (en) 2005-12-22
CA2569686A1 (en) 2005-12-22
RU2006147285A (ru) 2008-07-20
EP1753752A1 (en) 2007-02-21

Similar Documents

Publication Publication Date Title
DE602004017325D1 (de) (2s,4s)-4-fluor-1-ä4-fluor-beta-(4-fluorphenyl)-l-phenylalanylü-2-pyrrolidincarbonitril-p-toluolsulfonsäuresalz und wasserfreie kristalline formen davon
ATE326454T1 (de) Neue bernsteinsäure derivative als cysteine- protease-inhibitoren
DK1425273T3 (da) Fremgangsmåde til varmegenvinding
NO78493A (no) In situ-fremgangsmate for fremstilling av kvaternaere ammoniumbikarbonater og kvaternaere ammoniumkarbonater
TW200716556A (en) Methods of synthesizing 6-alkylaminoquinoline derivatives
DK1341749T3 (da) Fremgangsmåde til fremstilling af gabapentin
EA200701810A1 (ru) Производное изоксазолина и новый способ его получения
DE602005011113D1 (de) Morphinanderivate als mittel gegen juckreiz
MXPA03005429A (es) Procedimiento para preparacion de imidazotriazinonas sustituidas con sulfonamida.
ATE411994T1 (de) Herstellung eines substituierten chinoxalins von hoher reinheit
WO2002083634A3 (en) Process for the preparation of cefpodoxime acid
ATE309187T1 (de) Verfahren zur reinigung von abgasströmen
NO20063989L (no) Fremgangsmater for a produsere 3-O-beskyttede morfinoner og 3-O-beskyttede morfinondienol-karboksylater
TW200604187A (en) Highly selective novel amidation method
EA200900383A1 (ru) Хинолинилметильные соединения
NO20083025L (no) Fremgangsmate for fremstilling av 2-kloretoksy-eddiksyre-N,N-dimetylamid
EA200301224A1 (ru) Способ получения имипенема
DK1352050T3 (da) Mikrobiologisk fremgangsmåde til fremstilling af amider
DK1575952T3 (da) Syntese af heteroarylacetamider
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
WO2004085348A3 (en) Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone
DE50312458D1 (de) Iminosäurederivate als inhibitoren von matrix-metalloproteinasen
ATE266620T1 (de) Selektive reduktive aminierung von nitrilen
ATE520775T1 (de) Raygraspollen-spezifische promotoren und expressionskonstrukte
Li von Braun reaction

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application